Last updated: February 28, 2026
What is NDC 00169-7708?
NDC 00169-7708 refers to a specific drug listed in the National Drug Code (NDC) database. It corresponds to Fentanyl patches (Duragesic), used for chronic pain management in patients requiring opioid therapy.
Market Landscape
Competitive Positioning
Fentanyl patches are high-potency opioids primarily prescribed to patients with severe, persistent pain. Market competition is intense among branded products like Duragesic and generic equivalents. As of 2023, generics account for approximately 70% of the market share, with the remaining 30% held by branded formulations.
Market Size & Volume
- Global opioid analgesic market valued at $13.1 billion in 2022.
- Expected compound annual growth rate (CAGR): 4.2% (2023–2028).
- In the U.S., fentanyl patches contribute roughly $1.2 billion annually.
Key Market Drivers
- Rising prevalence of chronic pain conditions.
- Growing awareness and prescription of opioid analgesics.
- Expansion into emerging markets with developing healthcare infrastructure.
- Regulatory approval of newer formulations with improved safety profiles.
Challenges
- Stringent regulatory controls and increased scrutiny over opioid prescriptions.
- Rising incidence of opioid misuse and abuse.
- Competition from non-opioid pain therapies and multimodal pain management approaches.
Pricing Dynamics
Current Pricing Data
| Pricing Element |
2023 Data |
| Average wholesale price (AWP) per unit |
$30–$35 for a 72-hour patch |
| Estimated retail price per patch |
$150–$200 |
| Generic versions (per patch) |
$10–$15 |
| Average prescription size |
30 patches (monthly supply) |
| Monthly cost (brand) |
$4,500–$6,000 |
| Monthly cost (generic) |
$300–$450 |
Prices vary based on location, payer, and discounts negotiated.
Historical Price Trends
- 2018–2022: Slight decline due to increased generic availability. Brand prices held steady, averaging $150–$200 per patch.
- 2023 onward: Prices stabilized but show slight increases driven by inflation, manufacturing costs, and supply chain factors.
Projections
Short-term (2023–2025)
- Price decline expected in generics as more competitors enter the market, potentially lowering costs by 10–15% annualized.
- Brand product prices likely to remain stable or increase marginally due to inflationary pressures and manufacturing costs.
- Market volume expected to grow at 3.5–4% annually, aligning with overall opioid market growth.
Long-term (2026–2030)
- Emergence of alternative therapies (e.g., abuse-deterrent formulations, non-opioid options) could suppress demand.
- Pricing for branded fentanyl patches could decline by 20–30% over this period.
- Generics could potentially see further price reductions of 10–20%, depending on market consolidation and manufacturing efficiencies.
Impact of Regulatory Changes & Policy
- Stricter prescription controls may reduce volume by up to 10–15% over five years.
- Enhanced safety measures (e.g., abuse-deterrent features) might augment pricing for new formulations, but these are likely to be premium priced initially.
Strategic Considerations
- Companies prioritizing market share should focus on cost-effective generic manufacturing.
- Innovators developing safer, abuse-deterrent formulations can command premium pricing.
- Payers and policymakers' focus on reducing opioid misuse could limit reimbursement levels for high-cost formulations.
Summary
| Factor |
Current Status |
Projection |
| Market size |
~$1.2 billion (U.S. market) |
Grow at 3.5–4% annually |
| Generic market share |
70% |
Increase as patent exclusivity ends |
| Average price per patch |
$150–$200 (brand), $10–$15 (generic) |
Decline 10–15% (generics), stable (brand) |
| Long-term pricing |
Stable or declining due to competition |
20–30% decrease for branded, 10–20% for generics |
Key Takeaways
- The fentanyl patch market remains sizable but increasingly price-competitive.
- Generics dominate the market, driving down prices.
- Innovation in abuse-deterrent formulations could sustain premium pricing temporarily.
- Regulatory and policy pressures will shape volume and pricing dynamics through 2030.
FAQs
1. What factors influence the pricing of fentanyl patches?
Pricing depends on manufacturing costs, market competition, regulatory environment, and payer negotiations.
2. How will generics impact market prices long-term?
Generics are expected to continue pressuring prices downward as more competitors enter and manufacturing efficiencies improve.
3. What role do regulatory policies play in this market?
Policies aimed at curbing opioid abuse could limit prescriptions, reduce market volume, and influence price adjustments.
4. Are there emerging alternatives that could substitute fentanyl patches?
Yes. Non-opioid therapies, abuse-deterrent formulations, and novel delivery systems are under development.
5. How can companies maintain profitability amidst price declines?
By investing in new formulations, optimizing manufacturing for lower costs, and diversifying into adjacent pain management therapies.
Sources
[1] MarketWatch. (2023). Global opioid analgesic market analysis.
[2] IQVIA. (2023). Prescription trends for fentanyl formulations.
[3] FDA. (2022). Policies on opioid prescribing.
[4] Medical Economics. (2022). Pricing data for fentanyl patches.
[5] Statista. (2023). Industry revenue projections for pain management drugs.
